208 related articles for article (PubMed ID: 24041113)
1. Live attenuated rubella vectors expressing SIV and HIV vaccine antigens replicate and elicit durable immune responses in rhesus macaques.
Virnik K; Hockenbury M; Ni Y; Beren J; Pavlakis GN; Felber BK; Berkower I
Retrovirology; 2013 Sep; 10():99. PubMed ID: 24041113
[TBL] [Abstract][Full Text] [Related]
2. Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers.
Virnik K; Ni Y; Berkower I
Vaccine; 2012 Aug; 30(37):5453-8. PubMed ID: 22776214
[TBL] [Abstract][Full Text] [Related]
3. Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors.
Virnik K; Nesti E; Dail C; Hockenbury M; Ni Y; Felber BK; Schief WR; Berkower I
Vaccine; 2017 May; 35(24):3272-3278. PubMed ID: 28483193
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.
Virnik K; Ni Y; Berkower I
Vaccine; 2013 Apr; 31(17):2119-25. PubMed ID: 23474312
[TBL] [Abstract][Full Text] [Related]
5. Recombinant rubella vectors elicit SIV Gag-specific T cell responses with cytotoxic potential in rhesus macaques.
Rosati M; Alicea C; Kulkarni V; Virnik K; Hockenbury M; Sardesai NY; Pavlakis GN; Valentin A; Berkower I; Felber BK
Vaccine; 2015 Apr; 33(18):2167-74. PubMed ID: 25802183
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques.
Virnik K; Rosati M; Medvedev A; Scanlan A; Walsh G; Dayton F; Broderick KE; Lewis M; Bryson Y; Lifson JD; Ruprecht RM; Felber BK; Berkower I
PLoS One; 2020; 15(3):e0228163. PubMed ID: 32130229
[TBL] [Abstract][Full Text] [Related]
7. Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.
Penaloza MacMaster P; Shields JL; Alayo QA; Cabral C; Jimenez J; Mondesir J; Chandrashekar A; Cabral JM; Lim M; Iampietro MJ; Provine NM; Bricault CA; Seaman M; Orlinger K; Aspoeck A; Fuhrmann G; Lilja AE; Monath T; Mangeat B; Pinschewer DD; Barouch DH
Vaccine; 2017 Jan; 35(1):1-9. PubMed ID: 27899229
[TBL] [Abstract][Full Text] [Related]
8. Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.
Virnik K; Nesti E; Dail C; Scanlan A; Medvedev A; Vassell R; McGuire AT; Stamatatos L; Berkower I
Vaccine; 2018 Aug; 36(34):5166-5172. PubMed ID: 30037665
[TBL] [Abstract][Full Text] [Related]
9. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
Castro IM; Ricciardi MJ; Gonzalez-Nieto L; Rakasz EG; Lifson JD; Desrosiers RC; Watkins DI; Martins MA
J Virol; 2021 Jun; 95(14):e0033021. PubMed ID: 33910957
[TBL] [Abstract][Full Text] [Related]
11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
12. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
13. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
14. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.
Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132
[TBL] [Abstract][Full Text] [Related]
16. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
[TBL] [Abstract][Full Text] [Related]
17. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
[TBL] [Abstract][Full Text] [Related]
20. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication.
Boyer JD; Robinson TM; Maciag PC; Peng X; Johnson RS; Pavlakis G; Lewis MG; Shen A; Siliciano R; Brown CR; Weiner DB; Paterson Y
Virology; 2005 Mar; 333(1):88-101. PubMed ID: 15708595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
